Financière de Tubize SA
EBR:TUB.BR
Overview | Financials
Company Name | Financière de Tubize SA |
Symbol | TUB.BR |
Currency | EUR |
Price | 123.4 |
Market Cap | 5,492,854,840 |
Dividend Yield | 1.02% |
52-week-range | 60.8 - 128.6 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Ms. Anne Sophie Pijcke |
Website | https://www.financiere-tubize.be |
An error occurred while fetching data.
About Financière de Tubize SA
Financière de Tubize SA, through its interest in UCB, operates as a biopharmaceutical company worldwide. It discovers and develops medicines and solutions in the therapeutic areas of neurology and immunology diseases. The company's products include Cimzia for treating ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD